Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating rituximab with combination chemotherapy in primary central nervous system lymphoma; study terminated with results posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-06-28